Rhythm Pharmaceuticals Inc’s recently made public that its Corporate Controller & CAO German Christopher Paul unloaded Company’s shares for reported $18655.0 on Mar 21 ’25. In the deal valued at $54.23 per share,344 shares were sold. As a result of this transaction, German Christopher Paul now holds 2,889 shares worth roughly $0.16 million.
Then, Mazabraud Yann sold 75,000 shares, generating $3,861,272 in total proceeds. Upon selling the shares at $51.48, the EVP, Head of International now owns 40,370 shares.
Before that, YANN MAZZABRAUD bought 75,000 shares. Rhythm Pharmaceuticals Inc shares valued at $3,768,000 were divested by the Officer at a price of $50.24 per share.
A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. Oppenheimer began covering RYTM with “an Outperform” recommendation on December 20, 2024. Guggenheim started covering the stock on October 21, 2024. It rated RYTM as “a Buy”.
Price Performance Review of RYTM
On Monday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock jump 3.23% to $53.72. Over the last five days, the stock has gained 2.64%. Rhythm Pharmaceuticals Inc shares have fallen nearly -4.04% since the year began. Nevertheless, the stocks have risen 35.38% over the past one year. While a 52-week high of $68.58 was reached on 02/05/25, a 52-week low of $35.17 was recorded on 03/10/25. SMA at 50 days reached $55.28, while 200 days put it at $51.82.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 52.62, which if violated will result in even more drops to 51.51. On the upside, there is a resistance level at 54.33. A further resistance level may holdings at 54.94. The Relative Strength Index (RSI) on the 14-day chart is 50.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.45, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 26.84%. Stochastics %K at 68.29% indicates the stock is a holding.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2025-02-28, growing by 17473.0 shares to a total of 5.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 5.13 million shares. There was a rise of 0.34%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 18, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $64 price target.
